InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the complete record of transactions filed by Wentworth Kerry, Directeur Réglementaire. Director active across 1 companies, notably Flexion Therapeutics Inc. Cumulatively, 6 filings have been logged. Total volume traded: €43k. The latest transaction was disclosed on 19 November 2021 — Disposition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€1m140,843 shares@ €7.476997.7% of flow
Common Stock
SEC:0001209191-21-065709·
€1m140,843 shares@ €7.476948.8% of flow
Common Stock
SEC:0001209191-21-065709:0·
€21,5703,944 shares@ €5.4692.0% of flow
Common Stock
SEC:0001209191-21-047504·
€21,5703,944 shares@ €5.4691.0% of flow
Common Stock
SEC:0001209191-21-047504:0·
€3,520539 shares@ €6.53090.3% of flow
Common Stock
SEC:0001209191-21-043523·
€3,520539 shares@ €6.53090.2% of flow
Common Stock
SEC:0001209191-21-043523:0·
6 of 6 declarations
About Wentworth Kerry
Kerry Wentworth is the Chief Regulatory Officer at Flexion Therapeutics Inc. He is responsible for the company's regulatory compliance, ensuring that operations meet current standards. His role is essential for the reputation and compliance of Flexion Therapeutics Inc.
